Answer
Intravenous immunoglobulin (IVIg) reduces eculizumab serum levels and may reduce its effectiveness, so a supplemental eculizumab dose is required and effectiveness should be closely monitored.
Sources for this answer
- Soliris 300 mg concentrate for solution for infusionAlexion Pharma UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 29Document updated
Sources checked